SOCORRO PHARMACEUTICALS Trademark Information

Socorro Pharmaceuticals, LLC

Wholesale distributorship services featuring generic pharmaceuticals, generic veterinary preparations, and biosimilars; providing advertising, marketing and promotional services for generic pharmaceuticals, generic veterinary preparations, and biosimilars of others

Generic pharmaceutical research and development

This is a brand page for the SOCORRO PHARMACEUTICALS trademark by Socorro Pharmaceuticals, LLC  in Austin, TX, 78701.

Write a review about a product or service associated with this SOCORRO PHARMACEUTICALS trademark. Or, contact the owner Socorro Pharmaceuticals, LLC of the SOCORRO PHARMACEUTICALS trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the SOCORRO PHARMACEUTICALS trademark.

On Thursday, March 16, 2017, a U.S. federal trademark registration was filed for SOCORRO PHARMACEUTICALS. The USPTO has given the SOCORRO PHARMACEUTICALS trademark serial number of 87373562. The current federal status of this trademark filing is REGISTERED. The correspondent listed for SOCORRO PHARMACEUTICALS is REBECCA MCCURRY of PIRKEY BARBER PLLC, 600 CONGRESS AVENUE, SUITE 2120, AUSTIN, TX 78701 . The SOCORRO PHARMACEUTICALS trademark is filed in the category of Advertising, Business & Retail Services , Computer & Software Services & Scientific Services . The description provided to the USPTO for SOCORRO PHARMACEUTICALS is Antivirals; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention and treatment of cancer; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for use in dermatology; antifungal preparations; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for ophthalmological use; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of pain and inflammation; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, circulatory, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical and veterinary preparations, substances and biosimilars for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations, substances and biosimilars for use in chemotherapy; pharmaceutical and veterinary preparations, substances and biosimilars for use in urology; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of stress; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of diabetes; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of joint disorders; pharmaceutical and veterinary preparations, substances and biosimilars for controlling insulin levels; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of hypertension, hypercholesteremia, and hyperlipidemia; pharmaceutical preparations, substances and biosimilars for the prevention, treatment and alleviation of angina; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention and treatment of sexually transmitted diseases; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of sleep disorders; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical and veterinary preparations, substances and biosimilars, namely, fibrinolytic or thrombolytic agents; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of migraines; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of fungal infections; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of dermatophytosis, onychomycosis, tinea infections, and similar diseases of the skin and nails; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of ophthalmic and ocular disorders, diseases, conditions and ailments; ophthalmic; pharmaceuticals, namely, contact wetting and cleaning lens solutions, contact lens disinfectants, eye drops, solutions, gels, lubricants and ointments used for moisturizing the eye and to treat conditions such as dry eyes, allergies, inflammation, redness and itchy eyes; ophthalmic diagnostic test strips; viscoelastic preparations used in ophthalmic surgery; nasal spray preparations; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of erectile and sexual dysfunction; pharmaceutical and veterinary preparations, substances and biosimilars used in dialysis; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of epilepsy; pharmaceutical and veterinary preparations, substances and biosimilars for treating allergies; pharmaceutical and veterinary preparations, namely, injectable contraceptives; oral and chemical contraceptives; pharmaceutical and veterinary preparations, substances and biosimilars, namely, psychotropics; pharmaceutical preparations, substances and biosimilars for the treatment of gout; antibacterial pharmaceuticals and veterinary preparations, substances and biosimilars; pharmaceuticals and veterinary preparations, substances and biosimilars, namely, antimetics and emetics; anesthetics for surgical and non-surgical use; analgesics; sedatives; tranquilizers; antiparasitics; cough treatment preparations; muscle relaxants; steroids; appetite suppressants and stimulants; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of Lyme disease; hormonal preparations; anthelmintics; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of rheumatoid arthritis and arthritis; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of bacterial infections; veterinary vaccines; diagnostic preparations for veterinary purposes; stem cells for veterinary purposes; enzyme preparations for veterinary purposes; a full line of vitamins, minerals, and nutritional and dietary supplements for human consumption; Albumin dietary supplements; Alginate dietary supplements; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Bee pollen for use as a dietary food supplement; Beverages containing chlorophyll for use as a nutritional supplement; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Calcium supplements; Casein dietary supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement drink mixes; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplemental drinks; Dietary supplements for animals; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for pets; Dietary supplements for treatment of claustrophobia; Dietary supplements for urinary health; Dietary supp.

Word mark: SOCORRO PHARMACEUTICALS
Status/Status Date:
REGISTERED
6/26/2018
Serial Number: 87373562
Filing Date: 3/16/2017
Registration Number: 5504171
Registration Date: 6/26/2018
Goods and Services: Antivirals; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention and treatment of cancer; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for use in dermatology; antifungal preparations; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations, substances and biosimilars for ophthalmological use; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of pain and inflammation; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, circulatory, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical and veterinary preparations, substances and biosimilars for treating allergic rhinitis and asthma; pharmaceutical and veterinary preparations, substances and biosimilars for use in chemotherapy; pharmaceutical and veterinary preparations, substances and biosimilars for use in urology; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of stress; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of diabetes; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of joint disorders; pharmaceutical and veterinary preparations, substances and biosimilars for controlling insulin levels; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of hypertension, hypercholesteremia, and hyperlipidemia; pharmaceutical preparations, substances and biosimilars for the prevention, treatment and alleviation of angina; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention and treatment of sexually transmitted diseases; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of sleep disorders; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical and veterinary preparations, substances and biosimilars, namely, fibrinolytic or thrombolytic agents; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of migraines; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of fungal infections; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of dermatophytosis, onychomycosis, tinea infections, and similar diseases of the skin and nails; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of ophthalmic and ocular disorders, diseases, conditions and ailments; ophthalmic; pharmaceuticals, namely, contact wetting and cleaning lens solutions, contact lens disinfectants, eye drops, solutions, gels, lubricants and ointments used for moisturizing the eye and to treat conditions such as dry eyes, allergies, inflammation, redness and itchy eyes; ophthalmic diagnostic test strips; viscoelastic preparations used in ophthalmic surgery; nasal spray preparations; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of erectile and sexual dysfunction; pharmaceutical and veterinary preparations, substances and biosimilars used in dialysis; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of epilepsy; pharmaceutical and veterinary preparations, substances and biosimilars for treating allergies; pharmaceutical and veterinary preparations, namely, injectable contraceptives; oral and chemical contraceptives; pharmaceutical and veterinary preparations, substances and biosimilars, namely, psychotropics; pharmaceutical preparations, substances and biosimilars for the treatment of gout; antibacterial pharmaceuticals and veterinary preparations, substances and biosimilars; pharmaceuticals and veterinary preparations, substances and biosimilars, namely, antimetics and emetics; anesthetics for surgical and non-surgical use; analgesics; sedatives; tranquilizers; antiparasitics; cough treatment preparations; muscle relaxants; steroids; appetite suppressants and stimulants; pharmaceutical and veterinary preparations, substances and biosimilars for the treatment of Lyme disease; hormonal preparations; anthelmintics; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of rheumatoid arthritis and arthritis; pharmaceutical and veterinary preparations, substances and biosimilars for the prevention, treatment and alleviation of bacterial infections; veterinary vaccines; diagnostic preparations for veterinary purposes; stem cells for veterinary purposes; enzyme preparations for veterinary purposes; a full line of vitamins, minerals, and nutritional and dietary supplements for human consumption; Albumin dietary supplements; Alginate dietary supplements; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Bee pollen for use as a dietary food supplement; Beverages containing chlorophyll for use as a nutritional supplement; Calcium montmorillonite clay for therapeutic purposes used to enhance the production of enzymes in living beings or as a mineral supplement; Calcium supplements; Casein dietary supplements; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements used for weight loss; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary fiber for use as an ingredient in the manufacture of dietary supplements; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement drink mixes; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplemental drinks; Dietary supplements for animals; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for pets; Dietary supplements for treatment of claustrophobia; Dietary supplements for urinary health; Dietary supp
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 8/15/2017
Last Applicant/Owner: Socorro Pharmaceuticals, LLC
Austin, TX 78701
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: ("PHARMACEUTICALS")
Correspondent:
PIRKEY BARBER PLLC
600 CONGRESS AVENUE, SUITE 2120
AUSTIN, TX 78701

Trademark Events

Event Date: Event Description
2018-06-26 REGISTERED-PRINCIPAL REGISTER
2018-05-22 NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2018-05-21 ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2018-04-27 STATEMENT OF USE PROCESSING COMPLETE
2018-04-10 USE AMENDMENT FILED
2018-04-27 CASE ASSIGNED TO INTENT TO USE PARALEGAL
2018-04-10 TEAS STATEMENT OF USE RECEIVED
2017-10-10 NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2017-08-15 OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-08-15 PUBLISHED FOR OPPOSITION
2017-07-26 NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-06-12 APPROVED FOR PUB - PRINCIPAL REGISTER
2017-06-12 EXAMINER'S AMENDMENT ENTERED
2017-06-12 NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2017-06-12 EXAMINERS AMENDMENT E-MAILED
2017-06-12 EXAMINERS AMENDMENT -WRITTEN
2017-06-09 ASSIGNED TO EXAMINER
2017-03-22 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-03-20 NEW APPLICATION ENTERED IN TRAM

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (035)
Advertising; business management; business administration; office functions.
First Use Anywhere: : 5/15/2017
First Use In Commerce: 5/15/2017
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere: : 4/4/2017
First Use In Commerce: 4/4/2017

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your SOCORRO PHARMACEUTICALS trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.
Current Trademark Status:
6/26/2018
REGISTERED
Correspondent Search:

REBECCA MCCURRY is a correspondent of SOCORRO PHARMACEUTICALS trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!